These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 10559365

  • 1. Introduction of a cis-acting mutation in the capsid-coding gene of moloney murine leukemia virus extends its leukemogenic properties.
    Audit M, Déjardin J, Hohl B, Sidobre C, Hope TJ, Mougel M, Sitbon M.
    J Virol; 1999 Dec; 73(12):10472-9. PubMed ID: 10559365
    [Abstract] [Full Text] [Related]

  • 2. Different abilities of Friend murine leukemia virus (MuLV) and Moloney MuLV to induce promonocytic leukemia are due to determinants in both psi-gag-PR and env regions.
    Mukhopadhyaya R, Richardson J, Nazarov V, Corbin A, Koller R, Sitbon M, Wolff L.
    J Virol; 1994 Aug; 68(8):5100-7. PubMed ID: 7518530
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of the disease potential of a recombinant retrovirus containing Friend murine leukemia virus sequences and a unique long terminal repeat from feline leukemia virus.
    Nishigaki K, Hanson C, Thompson D, Yugawa T, Hisasue M, Tsujimoto H, Ruscetti S.
    J Virol; 2002 Feb; 76(3):1527-32. PubMed ID: 11773427
    [Abstract] [Full Text] [Related]

  • 6. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend-mink cell focus-forming and Moloney murine leukemia viruses.
    Ishimoto A, Takimoto M, Adachi A, Kakuyama M, Kato S, Kakimi K, Fukuoka K, Ogiu T, Matsuyama M.
    J Virol; 1987 Jun; 61(6):1861-6. PubMed ID: 3033317
    [Abstract] [Full Text] [Related]

  • 7. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M, Valk PJ, Vankan Y, de Both N, Löwenberg B, Delwel R.
    Virology; 2000 Mar 15; 268(2):308-18. PubMed ID: 10704339
    [Abstract] [Full Text] [Related]

  • 8. A Moloney murine leukemia virus-based retrovirus with 4070A long terminal repeat sequences induces a high incidence of myeloid as well as lymphoid neoplasms.
    Wolff L, Koller R, Hu X, Anver MR.
    J Virol; 2003 Apr 15; 77(8):4965-71. PubMed ID: 12663802
    [Abstract] [Full Text] [Related]

  • 9. Substitution of feline leukemia virus long terminal repeat sequences into murine leukemia virus alters the pattern of insertional activation and identifies new common insertion sites.
    Johnson C, Lobelle-Rich PA, Puetter A, Levy LS.
    J Virol; 2005 Jan 15; 79(1):57-66. PubMed ID: 15596801
    [Abstract] [Full Text] [Related]

  • 10. Mapping the viral sequences conferring leukemogenicity and disease specificity in Moloney and amphotropic murine leukemia viruses.
    DesGroseillers L, Jolicoeur P.
    J Virol; 1984 Nov 15; 52(2):448-56. PubMed ID: 6092670
    [Abstract] [Full Text] [Related]

  • 11. Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.
    Brightman BK, Farmer C, Fan H.
    J Virol; 1993 Dec 15; 67(12):7140-8. PubMed ID: 8230436
    [Abstract] [Full Text] [Related]

  • 12. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
    Brightman BK, Okimoto M, Kulkarni V, Lander JK, Fan H.
    Virology; 1998 Mar 01; 242(1):60-7. PubMed ID: 9501051
    [Abstract] [Full Text] [Related]

  • 13. Early dissemination rates of Friend murine leukaemia virus variants correlate with late pathogenesis.
    Bruland T, Dai HY, Lavik LA, Dalen A.
    APMIS; 2002 Dec 01; 110(12):899-912. PubMed ID: 12645669
    [Abstract] [Full Text] [Related]

  • 14. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
    Golemis E, Li Y, Fredrickson TN, Hartley JW, Hopkins N.
    J Virol; 1989 Jan 01; 63(1):328-37. PubMed ID: 2783259
    [Abstract] [Full Text] [Related]

  • 15. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties.
    Hanecak R, Pattengale PK, Fan H.
    J Virol; 1988 Jul 01; 62(7):2427-36. PubMed ID: 2836623
    [Abstract] [Full Text] [Related]

  • 16. Identification of genetic determinants responsible for the rapid immunosuppressive activity and the low leukemogenic potential of a variant of Friend leukemia virus, FIS-2.
    Dai HY, Troseth GI, Gunleksrud M, Bruland T, Solberg LA, Aarset H, Kristiansen LI, Dalen A.
    J Virol; 1998 Feb 01; 72(2):1244-51. PubMed ID: 9445024
    [Abstract] [Full Text] [Related]

  • 17. Functional reconstitution of lost activity of chemically cross-linked or mutant moloney murine leukemia virus nucleocapsid proteins by trans-complementation.
    Heldsinger A, Sharmeen L.
    Arch Virol; 2001 Dec 01; 146(12):2385-400. PubMed ID: 11811687
    [Abstract] [Full Text] [Related]

  • 18. Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.
    Lander JK, Chesebro B, Fan H.
    J Virol; 1999 Jul 01; 73(7):5671-80. PubMed ID: 10364317
    [Abstract] [Full Text] [Related]

  • 19. Tissue-specific replication of Friend and Moloney murine leukemia viruses in infected mice.
    Evans LH, Morrey JD.
    J Virol; 1987 May 01; 61(5):1350-7. PubMed ID: 3033265
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.